BLUFFDALE, Utah, May 4, 2021 /PRNewswire/ -- Med7, LLC (www.Med7cbd.com) and HempCo, Inc. announce the completion of a human clinical study in patients with Type II Diabetes using Purzorb® technology, now trademarked as Hempzorb81(TM). "This study will provide our customers and providers with evidence based products not seen to this point in the Industrial Hemp and CBD market place," said Matt Smith, CEO of Med7. This study was done with support...
Artikelen in de categorie 'Overige'
Recent nieuws in de categorie 'Overige'